期刊文献+

肉毒毒素注射与射频温控热凝术治疗原发性半侧面肌痉挛的疗效比较 被引量:2

Comparison of clinical efl'ects between hotulinum toxin injection and radiofrequency thermal rhizntomy intreatment of primary hemifacial spasm
原文传递
导出
摘要 目的时比肉毒毒素注射与射频温控热凝术治疗原发性单侧面肌痉挛的临床疗效.以寻求最佳的治疗方法。方法118例患者分别采用而部肌肉肉毒蓐素一A注射法勺向冲经总下射频温控热凝术治疗。治疗后随访.对两种治疗方式的疗效、并发症和复发率进行统计对比。结果肉毒毒素A注射疗法的近期疗效(1个月)优于射频温控热凝疗法,远期(6个月)疗效下降,复发牢72.5%.但引发面瘫并发症的概率极低;射频温控热凝术治疗的远期疗效优于肉毒毒素-A注射.6个月后复发牢仅为21.4%.但有出现治疗后面瘫并发症之虞。结论肉毒毒素-A注射和射频温挖热凝术相比较“各有千秋”,治疗后在短期内两者均具有较高的有效性,前者的副作用更小.但复发牢高.临床治疗中应当最情分别选用。 Objective To eompare the clinical effects of quency thermal rhizotom in the treatment of primary hemifacial hemifacial spasm patients were randomly divided inlo two groups, who were received botulinum toxin- A injections and radiofrequency thermal rhizotom treatment, respectively. Patients were followed up, and the curative effect, complications and recurrence rates of the two treatments were statistically compared. Results The early curative effect (1 month) for primary hemifacial spasm in botulinum toxin injection group was better than that in radiofrequency thermal rhizotom treatment group: recur fence rate of long term (6 months) was 72.5 %, but caused a very low risk of facial paralysis; radio- frequency thermal rhizotom treatment had a long term effect as compared with botulinurn toxin injec- tion, 6 months recurrence rate was 21.4%, with a low rate of postoperative facial paralysis. Conclu- sions Botulinum toxin injections is higher in short-term effectiveness and smaller in side effects as However, radiofrequency therma
出处 《中华医学美学美容杂志》 2012年第1期23-26,共4页 Chinese Journal of Medical Aesthetics and Cosmetology
基金 四川省卫生厅科学研究项目(编号:090006)
关键词 面神经痉挛 肉毒毒素-A 射频温控热凝术 面瘫 Facial nerve spasm Botulinum toxin A Radiofrequency thermal rhizolomy Facial paralysis
  • 相关文献

参考文献10

二级参考文献17

  • 1李晨军,张建设,郑维银,杨波.射频温控热凝术治疗原发性面肌痉挛[J].临床口腔医学杂志,2001,17(z1):29-30. 被引量:6
  • 2钟萍,蒋毅.A型肉毒毒素治疗半侧面肌痉挛的临床疗效评价[J].现代生物医学进展,2006,6(4):44-45. 被引量:1
  • 3SCOTT AB,KENNEDY RA,STUBBS HA. Botulinum A toxic injection as a treatment for blepharospasm[J]. Arch Ophthalmol,1985,103:347-350.
  • 4COHEN DA, SAVINO P, STERN MB, et al. Botulinum injection thePapy for blepharospasm:a review and report of 75 patients[J]. Chn .Neuropharmacol, 1986,9 : 415.
  • 5JOST WH, KOHL A. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm[J]. Neurol, 2001, 248:S21 -S24.
  • 6SCHANTZ EJ,JONSOS EA. Properties and use of botulinum toxin and other microtoxins in medicine[J]. Mic Rev, 1992,56:80.
  • 7SUPUTTITADA A, PHANTHUMCHINDA K, LOCHAR- ERNKUL C,et al. Hemifacial spasm:results of treatment with low dose botulinum toxin injection[J]. J Med Assoc Thail, 2004,87: 1205-1211.
  • 8SCHEIDT CE, SCHULLER B, RAYKI G, et al. Relative absence of psychopathology in benign essential blepharospasm and hemifacial spasm[J]. Neurology, 1996,47 : 43-45.
  • 9SCHNIDER P, BIRNER P, MORARU E, et al. Long-term treatment with botulinum toxin: dosage, treatment schedules and costs [J]. Wiener Klinische Wochenschrift, 1999,111 : 59-65.
  • 10WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment[J]. Psychol Med, 1998,28:551-558.

共引文献14

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部